Search Results - "Auchara Tangsathapornpong"
-
1
An epidemiological study of pediatric COVID-19 in the era of the variant of concern
Published in PloS one (15-04-2022)“…There were limited epidemiological data of pediatric COVID-19 in Asia outside China, especially during the era of the variants of concern such as the Delta and…”
Get full text
Journal Article -
2
Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study
Published in PloS one (29-08-2022)“…Background Due to the possibility of asymptomatic pneumonia in children with COVID-19 leading to overexposure to radiation and problems in limited-resource…”
Get full text
Journal Article -
3
Dengue amid COVID-19 pandemic
Published in PLOS global public health (2023)“…The increasing in dengue cases nowadays is a global threat concern. Fifty per cent of the world's population is vulnerable to dengue infection with Asia…”
Get full text
Journal Article -
4
Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital [version 1; peer review: awaiting peer review]
Published in F1000 research (2024)“…Background Respiratory syncytial virus (RSV) is one of the most significant respiratory pathogens that causes acute lower respiratory tract infections (LRTI)…”
Get full text
Journal Article -
5
Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital [version 2; peer review: 1 approved with reservations]
Published in F1000 research (01-01-2024)“…Background Respiratory syncytial virus (RSV) is one of the most significant respiratory pathogens that causes acute lower respiratory tract infections (LRTI)…”
Get full text
Journal Article -
6
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study
Published in Emerging microbes & infections (01-12-2022)“…Data on real-life vaccine effectiveness (VE), against the delta variant (B.1.617.2) of the severe acute respiratory syndrome coronavirus 2 among various…”
Get full text
Journal Article -
7
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial
Published in International journal of infectious diseases (01-05-2023)“…•The extended BNT162b2 dosing gives higher neutralizing antibodies against the Omicron variant.•BNT162b2 booster provides high neutralizing antibodies against…”
Get full text
Journal Article -
8
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
Published in Emerging microbes & infections (01-12-2023)“…The surge in coronavirus disease 2019 (COVID-19) caused by the Omicron variants of the severe acute respiratory syndrome coronavirus 2 necessitates researches…”
Get full text
Journal Article -
9
Development and validation of the predictive score for pediatric COVID-19 pneumonia: A nationwide, multicenter study
Published in PloS one (29-08-2022)“…Background Due to the possibility of asymptomatic pneumonia in children with COVID-19 leading to overexposure to radiation and problems in limited-resource…”
Get full text
Journal Article -
10
The burden of norovirus disease in children: a multi-country study in Chile, Brazil, Thailand and the Philippines
Published in International journal of infectious diseases (01-08-2021)“…•Norovirus (NoV) was frequent among 1294 children with acute gastroenteritis (AGE).•24% of AGE outpatient episodes and 18% of AGE hospitalizations were…”
Get full text
Journal Article -
11
Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era
Published in Frontiers in pediatrics (10-05-2023)“…The study of prevalence, risk factors, and vaccine effectiveness (VE) in children, adolescents, and young adults during the Omicron era has been limited,…”
Get full text
Journal Article -
12
Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
Published in Vaccines (Basel) (29-05-2022)“…Adolescents with underlying diseases are at risk of severe COVID-19. The immune response of BNT162b2 may be poor among immunocompromised adolescents. We aim to…”
Get full text
Journal Article -
13
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
Published in Frontiers in pediatrics (24-05-2023)“…The number of pediatric COVID-19 infections is increasing; however, the data on long COVID conditions in children is still limited. Our study aimed to find the…”
Get full text
Journal Article -
14
Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children
Published in Vaccine: X (01-12-2023)“…•A dose of BNT162b2 vaccine after COVID-19 provide high immune response.•Hybrid immunity provides a neutralizing antibody superior to 2 doses of…”
Get full text
Journal Article -
15
Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program
Published in Vaccines (Basel) (01-08-2022)“…To achieve the goal of measles elimination, herd immunity with 95% seroprotection in the community is required. This study aimed to describe the measles…”
Get full text
Journal Article -
16
Epidemiological and Clinical Characteristics of Pediatric COVID-19 in the Tertiary Care System in Thailand: Comparative Delta and pre-Delta Era
Published in Mediterranean journal of hematology and infectious diseases (2022)“…Few studies had focused on the epidemiological and clinical characteristics of pediatric COVID-19 (SARS-CoV-2) during Delta and pre-Delta eras in Asia, despite…”
Get full text
Journal Article -
17
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
Published in Vaccine: X (01-12-2022)“…•BNT162b2 following inactivated vaccines enhance antibodies against Omicron variant.•BNT162b2 following inactivated vaccines antibodies were higher than 2…”
Get full text
Journal Article -
18
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
Published in Vaccines (Basel) (27-02-2023)“…The changes in the severe acute respiratory syndrome coronavirus 2 and the tapering of immunity after vaccination have propelled the need for a booster dose…”
Get full text
Journal Article -
19
A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study
Published in Clinical and experimental otorhinolaryngology (01-06-2015)“…Cefditoren pivoxil (CDT) has been used in the treatment of rhinosinusitis. However, little is known about the efficacy of this drug at low and high doses. This…”
Get full text
Journal Article -
20
Zika in the MIDST of the COVID-19 Pandemic
Published in Asia-Pacific journal of public health (01-07-2022)Get full text
Journal Article